CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

NCT02937558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Hyperinsulinism

Interventions

DRUG: Glucagon
OTHER: Placebo

Sponsor

Xeris Pharmaceuticals

Collaborators

[object Object]